Targeting of immune system in anti-tumor combined therapies
Submission Deadline: 31 Dec 2020
Guest Editors
Keywords
- Cancer
- Immune System
- Therapeutics
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (4)
Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy
Front. Biosci. (Landmark Ed) 2022, 27(7), 203; https://doi.org/10.31083/j.fbl2707203
(This article belongs to the Special Issue Targeting of immune system in anti-tumor combined therapies)
Metabolic approaches to rescue antitumor Vγ9Vδ2 T-cell functions in myeloma
Front. Biosci. (Landmark Ed) 2020, 25(1), 69–105; https://doi.org/10.2741/4795
(This article belongs to the Special Issue Targeting of immune system in anti-tumor combined therapies)
Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives
Front. Biosci. (Landmark Ed) 2019, 24(7), 1284–1315; https://doi.org/10.2741/4780
(This article belongs to the Special Issue Targeting of immune system in anti-tumor combined therapies)
Macrophages at the crossroads of anticancer strategies
Front. Biosci. (Landmark Ed) 2019, 24(7), 1271–1283; https://doi.org/10.2741/4779
(This article belongs to the Special Issue Targeting of immune system in anti-tumor combined therapies)
